Rachna Shroff, MD, MS, FASCO

University of Arizona

Latest Content

Panel discussion on managing toxicity and expanding RAS therapy in pancreatic cancer featuring Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr. Shu.

PDAC at ASCO 2026

06/16/2026

Managing Toxicity and Expanding RAS Therapy in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Panel of oncology experts discussing the clinical impact of RASolution 302 in doubling patient survival.

PDAC at ASCO 2026

06/15/2026

Doubling Survival: The Clinical Impact of RASolute 302

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Panel discussion on drug development and clinical success in RAS-driven cancer, featuring experts Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr.

PDAC at ASCO 2026

06/14/2026

From Drug Design to Phase 3 Success in RAS-Driven Disease

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBA

Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, Dr. Shubham Panti discuss Daraxonrasib's impact on pancreatic cancer survival.

PDAC at ASCO 2026

06/13/2026

Daraxonrasib Delivers Breakthrough Survival Gains in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Two medical professionals, Joseph McCollom, DO, and Rachna Shroff, MD, MS, FASCO, discuss the latest updates on upper gastrointestinal cancer care at the Matterhorn conference.

Conferences

06/09/2026

GI Oncologists Discuss MATTERHORN Updates and Challenging HCC Subgroups

Joseph McCollom, DORachna Shroff, MD, MS, FASCO

Panel of medical experts discussing the impact of RASolute 302 on clinical practice for metastatic pancreatic ductal adenocarcinoma (PDAC).

PDAC at ASCO 2026

06/02/2026

Clinical Insights: Impact of RASolute 302 on Clinical Practice in Previously Treated Metastatic PDAC

Andrew H. Ko, MDShubham Pant, MD, MBBSEileen O'Reilly, MDRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

1. Expert panelists Dr. Rohit Gosain, Dr. Rachna Shroff, and Dr. Rahul Gosain discuss key insights on gastrointestinal cancers at the 2026 ASCO Gastrointestinal Cancers Symposium.

Gastric/GEJ Cancer

01/22/2026

4 Key Abstracts from the 2026 ASCO Gastrointestinal Cancers Symposium

Rachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Advanced medical conference featuring Dr. Rachna Shroff, Dr. Rohit Gosain, and Dr. Rahul Gosain discussing key updates on gastrointestinal cancer from ESMO 2025 in a professional setting.

GI Oncology

11/04/2025

5 Key GI Cancer Updates From ESMO 2025

Rachna Shroff, MD, MS, FASCORohit Gosain, MDRahul Gosain, MD, MBA